164 related articles for article (PubMed ID: 7724541)
1. Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase.
Djordjevic S; Roberts DL; Wang M; Shea T; Camitta MG; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3214-8. PubMed ID: 7724541
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
3. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.
Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP
J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989
[TBL] [Abstract][Full Text] [Related]
4. Cloning, purification, crystallization and preliminary X-ray analysis of a chimeric NADPH-cytochrome P450 reductase.
Aigrain L; Pompon D; Truan G; Moréra S
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Mar; 65(Pt 3):210-2. PubMed ID: 19255466
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
6. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
7. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
8. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
9. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of mosquito NADPH-cytochrome P450 reductase in Escherichia coli.
Kaewpa D; Boonsuepsakul S; Rongnoparut P
J Econ Entomol; 2007 Jun; 100(3):946-53. PubMed ID: 17598560
[TBL] [Abstract][Full Text] [Related]
11. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith GC; Tew DG; Wolf CR
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8710-4. PubMed ID: 8078947
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the FAD binding domain of cytochrome P450 reductase.
Hodgson AV; Strobel HW
Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and functional characterization of NADPH-dependent cytochrome P450 reductase from the green microalga Botryococcus braunii, B race.
Tsou CY; Matsunaga S; Okada S
J Biosci Bioeng; 2018 Jan; 125(1):30-37. PubMed ID: 28818427
[TBL] [Abstract][Full Text] [Related]
14. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
Jenkins CM; Waterman MR
Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
16. Engineering of proteolytically stable NADPH-cytochrome P450 reductase.
Bonina TA; Gilep AA; Estabrook RW; Usanov SA
Biochemistry (Mosc); 2005 Mar; 70(3):357-65. PubMed ID: 15823091
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning, bacterial expression and functional characterisation of cytochrome P450 monooxygenase, CYP97C27, and NADPH-cytochrome P450 reductase, CPR I, from Croton stellatopilosus Ohba.
Sintupachee S; Ngamrojanavanich N; Sitthithaworn W; De-Eknamkul W
Plant Sci; 2014 Dec; 229():131-141. PubMed ID: 25443840
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Purification of Recombinant Rat NADPH-P450 Reductase by Using a Hexahistidine-Tag.
Park HG; Lim YR; Han S; Jeong D; Kim D
J Microbiol Biotechnol; 2017 May; 27(5):983-989. PubMed ID: 28274101
[TBL] [Abstract][Full Text] [Related]
19. Purification, characterization, and cDNA cloning of an NADPH-cytochrome P450 reductase from mung bean.
Shet MS; Sathasivan K; Arlotto MA; Mehdy MC; Estabrook RW
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2890-4. PubMed ID: 8464904
[TBL] [Abstract][Full Text] [Related]
20. Crystallization studies of NADPH-cytochrome P450 reductase.
Kim JJ; Roberts DL; Djordjevic S; Wang M; Shea TM; Masters BS
Methods Enzymol; 1996; 272():368-77. PubMed ID: 8791796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
